24th Annual Symposium of The Protein Society

描述（由申请人提供）：第24届蛋白质学会研讨会将于2010年8月1日至5日在加利福尼亚州圣地亚哥的曼彻斯特君悦酒店举行，由David P. Goldenberg（犹他大学）组织。会议的主题是观察蛋白质：扩展视角和新技术。两个全体会议将以“大分子机器”和纪念弗雷德里克·理查兹的纪念会议为特色。2010年社会奖将分两次颁奖大会颁发，获奖者将发表演讲。科学会议将集中于蛋白质工程的溶解度和重构，成像和解构大复合物，蛋白质稳定性和药物配方，细胞中蛋白质的可视化，蛋白质治疗和诊断，无序蛋白质，蛋白质折叠，膜蛋白和受体，微流体和微阵列，金属蛋白，蛋白质设计，淀粉样蛋白和疾病。讲师，包括高水平的高级研究员（如Frances Arnold（加州理工学院），David Eisenberg（加州大学洛杉矶分校），Carlos Bustamante（加州大学伯克利分校），Silvia Cavagnero（威斯康星大学麦迪逊分校），Martha Bulyk（哈佛医学院-麻省理工学院）和Tomi Sawyer （Aileron Therapeutics, Inc.）等）和初级研究员，都是根据他们杰出的研究项目选择的。此外，该方案高度多样化，妇女和其他代表性不足的群体约占受邀演讲者的三分之一。我们的目标是吸引更多的生物医学领域的研究人员，从基础生物化学到人类治疗学，蛋白质在这些领域发挥着重要作用。我们的许多专题讨论会涵盖了与人类健康和疾病的广泛领域直接相关的主题：神经退行性疾病、癌症、传染病和心脏病。本次研讨会计划约有1300名与会者，包括来自美国和其他国家的本科生和研究生、博士后研究员以及初级和高级科学家。预计将有大约300名研究生和200名博士后参加会议。口头会议包括邀请演讲者和宣传海报讲座。会议期间将举行15场全体会议、60名特邀演讲人、30场宣传海报会议。海报会议共包括约400张海报。预计将提交约700份摘要。选择宣传海报演讲是为了代表最新的发展，并为本科生和研究生以及博士后提供在会议上发言的机会。1

DESCRIPTION (provided by applicant): The 24th Symposium of The Protein Society will be held August 1-5, 2010 at the Manchester Grand Hyatt in San Diego, California - organized by David P. Goldenberg (University of Utah). The meeting theme is Looking at Proteins: Expanding Perspectives & New Technologies. Two Plenary Sessions will feature "Macromolecular Machines" and a memorial session honoring Frederic Richards. The 2010 Society Awards will be presented in two Awards Plenary Sessions, and awardees will present plenary lectures. Scientific sessions will focus on Protein Engineering for Solubility and Reconstitution, Imaging and Deconstructing Large Complexes, Protein Stability and Drug Formulation, Visualizing Proteins in Cells, Protein Therapeutics and Diagnostics, Disordered Proteins, Protein Folding, Membrane Proteins and Receptors, Microfluidics and Microarrays, Metalloproteins, Protein Design, and Amyloids and Disease. Lecturers, including both high profile senior investigators (e.g., Frances Arnold (Caltech), David Eisenberg (UCLA), Carlos Bustamante (UC, Berkeley), Silvia Cavagnero (Univ of Wisconsin- Madison), Martha Bulyk (Harvard Medical School-MIT), and Tomi Sawyer (Aileron Therapeutics, Inc.), etc.) and junior investigators, were chosen on the basis of their outstanding research programs. In addition, the program is highly diverse with women and other underrepresented groups comprising approximately one third of the invited speakers. Our goal is to appeal to an expanded audience of researchers in biomedical fields where proteins play an important role, ranging from basic biochemistry to human therapeutics. Many of our symposia cover topics with direct relevance to broad areas of human health and disease: neurodegenerative disorders, cancer, infectious diseases, and heart disease. The symposium is planned for approximately 1,300 attendees, including undergraduate and graduate students, postdoctoral fellows, as well as junior and senior scientists from the U.S. and other countries. Approximately 300 graduate students and 200 postdoctoral fellows are expected to attend the meeting. Oral sessions include invited speakers and promoted poster talks. Fifteen plenary talks, 60 invited speakers and 30 promoted poster talks are scheduled during the meeting. The poster sessions include a total of approximately 400 posters. Approximately 700 abstract submissions are anticipated. Promoted poster talks are chosen to represent late-breaking developments and to provide an opportunity for undergraduate and graduate students as well as postdoctoral fellows to speak at the meeting. 1 PUBLIC HEALTH RELEVANCE: Our goal is to appeal to an expanded audience of researchers in biomedical fields where proteins play an important role, ranging from basic biochemistry and biophysics to cell biology to human therapeutics. Many of our symposia cover topics with direct relevance to broad areas of human health and disease: neurodegenerative disorders, cancer, infectious diseases, and heart disease-in scientific sessions focusing on Protein Engineering for Solubility and Reconstitution, Imaging and Deconstructing Large Complexes, Protein Stability and Drug Formulations, Visualizing Proteins in Cells, Protein Therapeutics and Diagnostics, Disordered Proteins, Protein Folding, Membrane Proteins and Receptors, Microfluidics and Microarrays, Metalloproteins, Protein Design, Amyloids and Disease, and Macromolecular Machines. We also have a number of speakers from industry, which should help to foster contacts and collaborations leading to translational research efforts. 1